CHEBI:231369 - savolitinib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name savolitinib
ChEBI ID CHEBI:231369
Definition A member of the class of triazolopyrazines that is 1H-[1,2,3]triazolo[4,5-b]pyrazine substituted by (1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl and 1-methyl-1H-pyrazol-4-yl groups at positions 1 and 6, respectively. It is a highly selective MET tyrosine kinase inhibitor that is approved in China for advanced NSCLC with MET exon 14 skipping mutations.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Delphine Zhou
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C17H15N9
Net Charge 0
Average Mass 345.370
Monoisotopic Mass 345.14504
InChI InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1
InChIKey XYDNMOZJKOGZLS-NSHDSACASA-N
SMILES C[C@H](N1N=NC2=NC=C(N=C12)C1=CN(C)N=C1)C1=CN2C=CN=C2C=C1
Roles Classification
Biological Role(s): c-Met tyrosine kinase inhibitor
An EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor that interferes with the action of c-Met tyrosine kinase.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing savolitinib (CHEBI:231369) has role antineoplastic agent (CHEBI:35610)
savolitinib (CHEBI:231369) has role c-Met tyrosine kinase inhibitor (CHEBI:90199)
savolitinib (CHEBI:231369) is a imidazopyridine (CHEBI:46908)
savolitinib (CHEBI:231369) is a pyrazoles (CHEBI:26410)
savolitinib (CHEBI:231369) is a triazolopyrazine (CHEBI:48277)
IUPAC Name
1-[(1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine
INNs Sources
savolitinib WHO MedNet
savolitinib WHO MedNet
savolitinib WHO MedNet
savolitinibum WHO MedNet
Synonyms Sources
1-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo[4,5-b]pyrazine ChEBI
3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine ChEBI
AZD 6094 ChEBI
AZD-6094 SUBMITTER
AZD6094 DrugBank
HM 5016504 ChEBI
HM-5016504 ChEBI
HMPL 504 ChEBI
HMPL-504 DrugBank
volitinib DrugBank
Brand Name Source
Orpathys ChEBI
Manual Xrefs Databases
D11139 KEGG DRUG
DB12048 DrugBank
Savolitinib Wikipedia
V0L PDBeChem
View more database links
Registry Number Type Source
1313725-88-0 CAS Registry Number KEGG DRUG
Citations Waiting for Citations Types Sources
25148209 PubMed citation Europe PMC
25779944 PubMed citation Europe PMC
28644771 PubMed citation Europe PMC
29191878 PubMed citation Europe PMC
30952639 PubMed citation Europe PMC
31531204 PubMed citation Europe PMC
31564914 PubMed citation Europe PMC
32027846 PubMed citation Europe PMC
32469384 PubMed citation Europe PMC
33052556 PubMed citation Europe PMC
33125717 PubMed citation Europe PMC
33400845 PubMed citation Europe PMC
34455538 PubMed citation Europe PMC
34590028 PubMed citation Europe PMC
36333268 PubMed citation Europe PMC
36339926 PubMed citation Europe PMC
36551608 PubMed citation Europe PMC
36808891 PubMed citation Europe PMC
36809050 PubMed citation Europe PMC
36811415 PubMed citation Europe PMC
36846984 PubMed citation Europe PMC
36888921 PubMed citation Europe PMC
36944506 PubMed citation Europe PMC
37078211 PubMed citation Europe PMC
37293311 PubMed citation Europe PMC
37315260 PubMed citation Europe PMC
37564044 PubMed citation Europe PMC
37835402 PubMed citation Europe PMC
38023194 PubMed citation Europe PMC
38145112 PubMed citation Europe PMC
38181277 PubMed citation Europe PMC
38182507 PubMed citation Europe PMC
38276867 PubMed citation Europe PMC
38313385 PubMed citation Europe PMC
38380365 PubMed citation Europe PMC
38385995 PubMed citation Europe PMC
38525101 PubMed citation Europe PMC
38599970 PubMed citation Europe PMC
Last Modified
09 May 2024